Skip to main content
MTMedTechNet
Open navigation

Stage 12 of 12

Scale-up

Improve cost, capacity, resilience, and geographic reach.

Entry criteria

  • Launch performance and demand are measurable
  • Core production and support processes are stable
  • Improvement priorities are evidence-based

Required activities

  • Increase capacity and automate appropriate processes
  • Reduce cost through controlled design and sourcing changes
  • Qualify second sources and additional sites
  • Plan new markets, indications, and product variants

Expected deliverables

  • Capacity and cost-reduction roadmap
  • Second-source qualifications
  • Validated process improvements
  • Market and portfolio expansion plan

Recommended capabilities

Look for providers with relevant device, market, and stage experience—not capability labels alone.

Common risks

  • Cost changes undermining verified performance
  • Quality-system strain during rapid growth
  • Uncoordinated geographic or portfolio expansion

Exit criteria

  • Capacity, quality, and unit economics meet scale targets
  • Supply continuity risks have active mitigations
  • Expansion changes remain controlled and traceable

Suggested next actions

  • Reassess roadmap maturity regularly
  • Use field evidence to drive portfolio decisions
  • Maintain resilient suppliers and quality systems

Find your next move

Build confidence in scale-up.

Map your current evidence and gaps to the capabilities needed for this stage.